Fang HW#, Tseng PL#(co-first), Hu TH, Wang JH, Hung CH, Lu SN, Chen CH*. Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy. Virol J. 2024 Apr 3;21(1):79. (SCI)
Fang HW, Hu TH, Wang JH, Hung CH, Lu SN, Chen CH*. Post-treatment HBsAg decline predicts high rate of HBsAg loss after stopping entecavir or tenofovir in HBeAg-negative patients without retreatment. Dig Liver Dis. 2023 Sep;55(9):1223-1229. (SCI)
Fang HW, Yen YH, Hung CH, Wang JH, Hu TH, Lu SN, Chen CH*. Predictors of Virological Suppression After Clinical Relapse in Patients Who Discontinued Entecavir orTenofovir. Dig Dis Sci. 2022 Jul;67(7):3402-3411. (SCI)
Fang HW, Chiang PH, Huang YC*. Livestock-associated methicillin-resistant Staphylococcus aureus ST9 in pigs and related personnel in Taiwan. PLoS One. 2014 Feb 13;9(2):e88826. (SCI)
